Clinical Trial Update: Radioembolization Trial Utilizing Eye90 Microspheres™ for the Treatment of Hepatocellular Carcinoma (HCC) [NA]

View source ↗

Summary

An ongoing trial evaluating Eye90 Microspheres for hepatocellular carcinoma is currently active but not recruiting, including non-resectable cases.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Eye90 Microspheres

Snippet

Sponsor: ABK Biomedical | Conditions: Hepatocellular Carcinoma, Hepatocellular Carcinoma Non-resectable | NA | Status: ACTIVE_NOT_RECRUITING